Boomerang Ventures

BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.

Back to News Page

In the News
In The news

IU Grad Launches Device to Help People Quit Vaping

Source: Inside INdiana Business
Indianapolis-based startup HabitHalo is helping people quit vaping through its innovative RipLok device, which combines smart hardware and personalized technology to gradually reduce vape use. Founded by IU graduate Phil Tran, HabitHalo is transforming personal experience into a mission-driven solution for healthier habits.

Read More »
In the News
In The news

SynchNeuro Gains Seed-Stage Support from Boomerang Ventures | StartUp Health Insights

Source: Startup Health
SynchNeuro has secured seed-stage support from Boomerang Ventures to advance its brain-based, non-invasive continuous glucose monitoring technology. Using EEG-derived signals decoded by machine learning, the company is developing a wearable “Cardiometabolic Advisor” that tracks blood glucose and metabolic indicators without needles. The investment accelerates development and moves the device closer to broad market adoption.

Read More »
In the News
In The news

SynchNeuro Secures Seed Funding From Boomerang Ventures

Source: CityBiz
SynchNeuro, a Philadelphia-based health-technology startup founded by neurosurgeon Dr. Casey Halpern, has secured seed funding from Boomerang Ventures. The company is developing a non-invasive EEG-based platform that decodes brain-signal activity into metabolic insights, aiming to support individuals with prediabetes and early-stage Type 2 diabetes. The investment will help expand operations and accelerate product development.

Read More »
Press Release: Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology
Press Releases

Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology

Boomerang Ventures has announced a seed-stage investment in SynchNeuro, a pioneering neurotechnology company developing the world’s first brain-based, non-invasive continuous glucose monitor. The partnership accelerates SynchNeuro’s mission to revolutionize cardiometabolic health through EEG-based technology that interprets brain signals to track blood glucose and other vital metrics in real time. This innovative approach aims to make proactive, pain-free, and affordable glucose monitoring accessible to millions.

Read More »
In the News
In The news

Business Insider Covers HabitHalo App Launch

Source: Business Insider
Boomerang Ventures portfolio company HabitHalo was recently featured in Business Insider for the launch of its Quit Vaping App, a one-time purchase tool that delivers data-driven support to help users reduce or quit nicotine use. The article highlights the app’s personalized approach, real-time tracking, and science-backed foundation built by founder Phil Tran and the HabitHalo team.

Read More »
In the News
In The news

TechPoint Spotlights HabitHalo Quit Vaping App Launch

Source: TechPoint
TechPoint featured HabitHalo, a Boomerang Ventures portfolio company, for the launch of its Quit Vaping App. The article spotlights HabitHalo’s mission to empower users with real-time tracking, personalized plans, and motivational tools to support a nicotine-free life. Designed by founder Phil Tran and supported by Boomerang Ventures, the app is a meaningful step forward in connected health innovation.

Read More »
HabitHalo Launches Quit Vaping App, Bringing Data-Driven Support to Users Looking to Reduce or Quit Nicotine Use
Press Releases

HabitHalo Launches Quit Vaping App, Bringing Data-Driven Support to Users Looking to Reduce or Quit Nicotine Use

HabitHalo, a Boomerang Ventures portfolio company, has launched the HabitHalo: Quit Vaping App—a $9.99 one-time purchase that delivers personalized, data-driven tools to help users monitor, reduce, or quit nicotine use. With features like puff tracking, intelligent sleep mode, and motivational cues, the app offers a smarter, science-backed approach to vaping cessation.

Read More »
Boomerang Ventures Completes Series A2 Round in Wicked Technologies to Advance Incontinence Care Innovation
Press Releases

Boomerang Ventures Completes Series A2 Round in Wicked Technologies to Advance Incontinence Care Innovation

Boomerang Ventures has completed a $2.1 million Series A2 funding round for Wicked Technologies, a company revolutionizing incontinence care with the Wicked Smart Pad™. This AI-powered, sensorized solution provides real-time moisture detection and alerts to caregivers, improving patient care and operational efficiency in senior living communities. The funding will drive FDA registration, expand pilot programs, and accelerate commercialization.

Read More »

Back to News Page

Boomerang Ventures
Loading...